FIGURE 5.

KEAP1 mutation is associated with survival after receiving immunotherapy in LUADs. Kaplan–Meier survival curves of KEAP1 mutated versus wild type LUADs for their overall survival (a) and release‐free survival (b). (c) Kaplan–Meier survival curves for the overall survival of KEAP1‐mutated versus wild type LUADs after receiving immunotherapy. (d) Multivariate Cox analysis with age, TMB, drug, and KEAP1 status as cofounding factors. Square data markers indicate estimated hazard ratios (HRs), and error bars represent 95% CIs. The p‐value was estimated with log‐rank test, and Cox analysis was applied to estimate HR